MICHELLE LYNN PLASTER M.D. NPI 1073762720

NPI Details

Michelle Lynn Plaster, M.D. is a family medicine in Monroe, GA with 21 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Michelle Lynn Plaster, M.D. NPI is 1073762720. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1016 E SPRING ST
MONROE, GA
ZIP 30655-469
Phone: (770) 464-0280
Fax: (770) 464-0233

The NPI 1073762720 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Therapy procedure using manual technique, each 15 minutes (HCPCS:97140)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes (HCPCS:G0446)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Face-to-face behavioral counseling for obesity, 15 minutes (HCPCS:G0447)
• Automated urinalysis test (HCPCS:81003)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Hemoglobin a1c level (HCPCS:83036)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Test to measure rate of airflow (HCPCS:94375)
• Ultrasound scan of head and neck soft tissue (HCPCS:76536)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use (HCPCS:90671)

The enumeration date for this NPI number is 9/17/2008 and was last updated on 9/4/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: